Skip to content

Aardvark Therapeutics, Inc.

AARD· NasdaqCore metricsCIK 1774857

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.52%
Market cap
$33.93M
21.89M shares
Filings
120
$0.00
Q3 2026
—
-$19.19M
Q3 2026N/M FY25 yoy
-$19.72M
Q3 2026N/M FY25 yoy
-$50.00M
Q3 2026derivedN/M FY25 yoy
-$0.88
Q3 2026N/M FY25 yoy
$60.34M
Q3 2026−23.7% FY25 yoy
$33.93M
—
—
0.6×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$1.5585.86%$9.41past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$0.000FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported

Pharmaceutical preparations

Aardvark Therapeutics, Inc. is the 354th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Aardvark Therapeutics, Inc. · CIK 1774857 · Engraved from SEC EDGAR